Faisal Nabi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Faisal Nabi has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Rizwan Hasan Khan
Aligarh Muslim University
7 shared publications - Mouaz Husayn Al-Mallah
Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Academic Institute, Houston, TX, USA
3 shared publications - Ahmed Ibrahim Ahmed
Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA
2 shared publications Aiman Masroor
2 shared publications- Basil Al-Sabeq
Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas
2 shared publications Fahad M. Almutairi
Physical Biochemistry Research Laboratory, Department of Biochemistry, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia
2 shared publications
Latest Publications
- 27 August 2026
- Published by American Chemical Society (ACS) in Biochemistry
Triprolidine Interferes with α-Synuclein Fibrillation and Remodels Aggregate Structure via Conformational Modulation
Parkinson’s disease (PD) is characterized by the pathological aggregation of α-synuclein (α-syn) into β-sheet-rich fibrils, contributing to neuronal toxicity and oxidative stress. In this study, we investigated the inhibitory and disaggregating effects of Triprolidine (TC) on α-syn fibrillation through a combined experimental and computational approach. Biophysical assays, including ThT assay, DLS, and ANS assays, demonstrated that TC inhibits α-syn fibrillation in a concentration-dependent manner (IC50 ≈ 255 μM), disrupts preformed fibrils, and maintains the protein’s native form. CD data further revealed that TC prevents the transition of α-syn to its toxic β-sheet-rich form and facilitates partial structural reversal during disaggregation. To elucidate the molecular mechanism of inhibition, we performed all-atom molecular dynamics (MD) simulations followed by Markov State Model (MSM) construction. The simulations revealed that TC binding remodels the conformational landscape of α-syn by stabilizing compact, disordered states and reducing the population of β-sheet-prone intermediates, particularly in the aggregation-prone NAC region. MSM analysis identified metastable states with diminished aggregation potential and reduced inter-residue contact probability, offering mechanistic insights into how TC interferes with early nucleation events. TC attenuates seeded fibrillation in a concentration-dependent manner too. Complementary cellular assays, including MTT and hemolytic assays, confirmed a significant reduction in α-syn-induced cytotoxicity upon TC treatment, with a decrease in ROS levels as confirmed by the DCFH-DA assay. Together, these findings demonstrate that TC modulates both the structural dynamics and functional toxicity of α-synuclein, and highlight its potential as a promising chemical modulator for further investigation in PD-related protein aggregation.
- 27 August 2026
- Published by American Chemical Society (ACS) in Biochemistry
Triprolidine Interferes with α-Synuclein Fibrillation and Remodels Aggregate Structure via Conformational Modulation
Parkinson’s disease (PD) is characterized by the pathological aggregation of α-synuclein (α-syn) into β-sheet-rich fibrils, contributing to neuronal toxicity and oxidative stress. In this study, we investigated the inhibitory and disaggregating effects of Triprolidine (TC) on α-syn fibrillation through a combined experimental and computational approach. Biophysical assays, including ThT assay, DLS, and ANS assays, demonstrated that TC inhibits α-syn fibrillation in a concentration-dependent manner (IC50 ≈ 255 μM), disrupts preformed fibrils, and maintains the protein’s native form. CD data further revealed that TC prevents the transition of α-syn to its toxic β-sheet-rich form and facilitates partial structural reversal during disaggregation. To elucidate the molecular mechanism of inhibition, we performed all-atom molecular dynamics (MD) simulations followed by Markov State Model (MSM) construction. The simulations revealed that TC binding remodels the conformational landscape of α-syn by stabilizing compact, disordered states and reducing the population of β-sheet-prone intermediates, particularly in the aggregation-prone NAC region. MSM analysis identified metastable states with diminished aggregation potential and reduced inter-residue contact probability, offering mechanistic insights into how TC interferes with early nucleation events. TC attenuates seeded fibrillation in a concentration-dependent manner too. Complementary cellular assays, including MTT and hemolytic assays, confirmed a significant reduction in α-syn-induced cytotoxicity upon TC treatment, with a decrease in ROS levels as confirmed by the DCFH-DA assay. Together, these findings demonstrate that TC modulates both the structural dynamics and functional toxicity of α-synuclein, and highlight its potential as a promising chemical modulator for further investigation in PD-related protein aggregation.
- 23 August 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- p. 1-12
Levofloxacin-Induced Insulin Aggregation: Biophysical and Computational Insights into Amyloidogenic Potential
Protein misfolding, a hallmark of conformational diseases known as proteinopathies, arises when hydrophobic regions of proteins are exposed, leading to aggregation, loss of functionality and potential cytotoxicity. With the increasing prevalence of multidrug-resistant bacteria, repurposing antibiotics has gained attention for therapeutic applications beyond their conventional use. In this study, we investigated the amyloidogenic and anti-amyloidogenic potential of levofloxacin (LFX) using human insulin (HI) as a model, given its propensity to aggregate at injection sites in diabetes patients. Using various biophysical techniques, we observed a concentration-dependent increase in light scattering (LS) intensity and a corresponding rise in Thioflavin T (ThT) fluorescence intensity in the presence of LFX, indicating enhanced amyloid formation. Time-dependent ThT measurements revealed a shortened lag phase and a higher apparent rate constant for HI fibrillation under LFX exposure. Circular dichroism (CD) spectra showed a negative peak at 218 nm, signifying a transition to [ ]-sheet-rich structures, consistent with amyloid formation. Complementary in silico analyses corroborated these findings, with DSSP-based secondary structure analysis and Ramachandran plots confirming significant [ ]-sheet enrichment induced by LFX. These results suggest that LFX promotes HI aggregation, raising important implications for diabetic patients where LFX may exacerbate aggregation-related complications. This research underscores the critical need for evaluating potential interactions between antibiotics and proteins prone to misfolding, particularly in vulnerable populations. Beyond highlighting the risks of unintended drug-induced protein aggregation, this work also emphasizes the broader public health importance of raising awareness about drug interactions to minimize adverse effects, reduce healthcare costs and improve patient outcomes. By providing insights into the amyloidogenic potential of LFX, this study contributes to the understanding of antibiotic–protein interactions, paving the way for safer therapeutic applications and better management strategies in clinical practice.
- 23 August 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- p. 1-12
Levofloxacin-Induced Insulin Aggregation: Biophysical and Computational Insights into Amyloidogenic Potential
Protein misfolding, a hallmark of conformational diseases known as proteinopathies, arises when hydrophobic regions of proteins are exposed, leading to aggregation, loss of functionality and potential cytotoxicity. With the increasing prevalence of multidrug-resistant bacteria, repurposing antibiotics has gained attention for therapeutic applications beyond their conventional use. In this study, we investigated the amyloidogenic and anti-amyloidogenic potential of levofloxacin (LFX) using human insulin (HI) as a model, given its propensity to aggregate at injection sites in diabetes patients. Using various biophysical techniques, we observed a concentration-dependent increase in light scattering (LS) intensity and a corresponding rise in Thioflavin T (ThT) fluorescence intensity in the presence of LFX, indicating enhanced amyloid formation. Time-dependent ThT measurements revealed a shortened lag phase and a higher apparent rate constant for HI fibrillation under LFX exposure. Circular dichroism (CD) spectra showed a negative peak at 218 nm, signifying a transition to [ ]-sheet-rich structures, consistent with amyloid formation. Complementary in silico analyses corroborated these findings, with DSSP-based secondary structure analysis and Ramachandran plots confirming significant [ ]-sheet enrichment induced by LFX. These results suggest that LFX promotes HI aggregation, raising important implications for diabetic patients where LFX may exacerbate aggregation-related complications. This research underscores the critical need for evaluating potential interactions between antibiotics and proteins prone to misfolding, particularly in vulnerable populations. Beyond highlighting the risks of unintended drug-induced protein aggregation, this work also emphasizes the broader public health importance of raising awareness about drug interactions to minimize adverse effects, reduce healthcare costs and improve patient outcomes. By providing insights into the amyloidogenic potential of LFX, this study contributes to the understanding of antibiotic–protein interactions, paving the way for safer therapeutic applications and better management strategies in clinical practice.
- 29 April 2024
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 128 (18) , 4283-4300
Furosemide Derails Human Lysozyme Fibrillation by Interacting with Aggregation Hot Spots: A Biophysical Comprehension
Kidney-associated human lysozyme amyloidosis leads to renal impairments;thus, patients are often prescribed furosemide. Based on this fact, the effect of furosemide on induced human lysozyme fibrillation, in vitro, is evaluated by spectroscopic, calorimetric, computational, and cellular-based assays/methods. Results show that furosemide increases the lag phase and decreases the apparent rate of aggregation of human lysozyme, thereby decelerating the nucleation phase and amyloid fibril formation, as confirmed by the decrease in the level of Thioflavin-T fluorescence. Fewer entities of hydrodynamic radii of ∼171 nm instead of amyloid fibrils (∼412 nm) are detected in human lysozyme in the presence of furosemide by dynamic light scattering. Moreover, furosemide decreases the extent of conversion of the α/β structure of human lysozyme into a predominant β-sheet. The isothermal titration calorimetry established that furosemide forms a complex with human lysozyme, which was also confirmed through fluorescence quenching and computational studies. Also, human lysozyme lytic activity is inhibited competitively by furosemide due to the involvement of amino acid residues of the active site in catalysis, as well as complex formation. Conclusively, furosemide interacts with Gln58, Ile59, Asn60, Ala108, and Trp109 of aggregation-prone regions 2 and 4 of human lysozyme, thereby masking its sites of aggregation and generating only lower-order entities that are less toxic to red blood cells than the fibrils. Thus, furosemide slows the progression of amyloid fibrillation in human lysozyme.
- 29 April 2024
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 128 (18) , 4283-4300
Furosemide Derails Human Lysozyme Fibrillation by Interacting with Aggregation Hot Spots: A Biophysical Comprehension
Kidney-associated human lysozyme amyloidosis leads to renal impairments;thus, patients are often prescribed furosemide. Based on this fact, the effect of furosemide on induced human lysozyme fibrillation, in vitro, is evaluated by spectroscopic, calorimetric, computational, and cellular-based assays/methods. Results show that furosemide increases the lag phase and decreases the apparent rate of aggregation of human lysozyme, thereby decelerating the nucleation phase and amyloid fibril formation, as confirmed by the decrease in the level of Thioflavin-T fluorescence. Fewer entities of hydrodynamic radii of ∼171 nm instead of amyloid fibrils (∼412 nm) are detected in human lysozyme in the presence of furosemide by dynamic light scattering. Moreover, furosemide decreases the extent of conversion of the α/β structure of human lysozyme into a predominant β-sheet. The isothermal titration calorimetry established that furosemide forms a complex with human lysozyme, which was also confirmed through fluorescence quenching and computational studies. Also, human lysozyme lytic activity is inhibited competitively by furosemide due to the involvement of amino acid residues of the active site in catalysis, as well as complex formation. Conclusively, furosemide interacts with Gln58, Ile59, Asn60, Ala108, and Trp109 of aggregation-prone regions 2 and 4 of human lysozyme, thereby masking its sites of aggregation and generating only lower-order entities that are less toxic to red blood cells than the fibrils. Thus, furosemide slows the progression of amyloid fibrillation in human lysozyme.
- 2 May 2023
- Published by Elsevier in Biophysical Chemistry
- Vol. 298, 107029
Mechanistic and biophysical insight into the inhibitory and disaggregase role of antibiotic moxifloxacin on human lysozyme amyloid formation
- 2 May 2023
- Published by Elsevier in Biophysical Chemistry
- Vol. 298, 107029
Mechanistic and biophysical insight into the inhibitory and disaggregase role of antibiotic moxifloxacin on human lysozyme amyloid formation
- 10 September 2022
- Published by Elsevier in International Journal of Cardiology
- Vol. 371, 465-471
Incremental prognostic value of digital positron emission tomography derived myocardial flow reserve: A prospective cohort study
- 10 September 2022
- Published by Elsevier in International Journal of Cardiology
- Vol. 371, 465-471
Incremental prognostic value of digital positron emission tomography derived myocardial flow reserve: A prospective cohort study
- 5 August 2022
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 13 (16) , 2529-2539
Moxifloxacin Disrupts and Attenuates Aβ42 Fibril and Oligomer Formation: Plausibly Repositioning an Antibiotic as Therapeutic against Alzheimer’s Disease
The aggregation of Aβ42 is established as a key factor in the development of Alzheimer's disease (AD). Consequently, molecules that inhibit aggregation of peptide may lead to therapies to prevent or control AD. Several studies suggest that oligomeric intermediates present during aggregation may be more cytotoxic than fibrils themselves. In this work, we examine the inhibitory activity of an antibiotic MXF on aggregation (fibrils and oligomers) and disaggregation of Aβ42 using various biophysical and microscopic studies. Computational analysis was done to offer mechanistic insight. The amyloid formation of Aβ42 is suppressed by MXF, as demonstrated by the decrease in both the corresponding ThT fluorescence intensity and other biophysical techniques. The lag phase of amyloid formation doubled from 4.53 to 9.66 h in the presence of MXF. The addition of MXF at the completion of the fibrillation reaction, as monitored by ThT, led to a rapid, concentration dependent, exponential decrease in fluorescence signal that was consistent with loss of fibrils. We used TEM to directly demonstrate that MXF caused fibrils to disassemble. Our docking results show that MXF binds to both monomeric and fibrillar forms of Aβ42 with significant affinities. We also observed breaking of fibrils in the presence of MXF through molecular dynamics simulation. These findings suggest that antibiotic MXF could be a promising lead compound with dual role as fibril/oligomer inhibitor and disaggregase for further development as potential repurposed therapeutic against AD.
- 5 August 2022
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 13 (16) , 2529-2539
Moxifloxacin Disrupts and Attenuates Aβ42 Fibril and Oligomer Formation: Plausibly Repositioning an Antibiotic as Therapeutic against Alzheimer’s Disease
The aggregation of Aβ42 is established as a key factor in the development of Alzheimer's disease (AD). Consequently, molecules that inhibit aggregation of peptide may lead to therapies to prevent or control AD. Several studies suggest that oligomeric intermediates present during aggregation may be more cytotoxic than fibrils themselves. In this work, we examine the inhibitory activity of an antibiotic MXF on aggregation (fibrils and oligomers) and disaggregation of Aβ42 using various biophysical and microscopic studies. Computational analysis was done to offer mechanistic insight. The amyloid formation of Aβ42 is suppressed by MXF, as demonstrated by the decrease in both the corresponding ThT fluorescence intensity and other biophysical techniques. The lag phase of amyloid formation doubled from 4.53 to 9.66 h in the presence of MXF. The addition of MXF at the completion of the fibrillation reaction, as monitored by ThT, led to a rapid, concentration dependent, exponential decrease in fluorescence signal that was consistent with loss of fibrils. We used TEM to directly demonstrate that MXF caused fibrils to disassemble. Our docking results show that MXF binds to both monomeric and fibrillar forms of Aβ42 with significant affinities. We also observed breaking of fibrils in the presence of MXF through molecular dynamics simulation. These findings suggest that antibiotic MXF could be a promising lead compound with dual role as fibril/oligomer inhibitor and disaggregase for further development as potential repurposed therapeutic against AD.
- 1 December 2021
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 28 (41) , 8480-8495
Transcriptional Control of the Oxidative Stress Response and Implications of Using Plant Derived Molecules for Therapeutic Interventions in Cancer
: The oxidative stress response is critical for malignant cells. It plays a dual role by helping cancer cells survive and proliferate but also causing apoptosis and apoptosis-- like cell death. The oxidative stress response is characterized by tight regulation of gene expression by a series of transcription factors (OSRts; oxidative stress response transcription factors). In this communication, we review the role of OSRts, notably NRF2 and p53 as well as other transcription factors that modulate the response. We discuss how hierarchal the oxidative stress response is and controls ‘live or die’ signals. This is followed by a discussion on how plant-derived molecules, including polyphenols, which are described both as prooxidants and antioxidants within the cancer cells, have been reported to affect the activities of OSRts. Deriving an example from preliminary data from our group, we discuss how plant-derived molecules might modulate the oxidative stress response by causing structural perturbations in the proteinaceous transcription factors, notably Nrf2 and p53. We look at this information in the light of understanding how plant derived molecules may be used as lead compounds to develop modulators of the oxidative stress response.
- 1 December 2021
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 28 (41) , 8480-8495
Transcriptional Control of the Oxidative Stress Response and Implications of Using Plant Derived Molecules for Therapeutic Interventions in Cancer
: The oxidative stress response is critical for malignant cells. It plays a dual role by helping cancer cells survive and proliferate but also causing apoptosis and apoptosis-- like cell death. The oxidative stress response is characterized by tight regulation of gene expression by a series of transcription factors (OSRts; oxidative stress response transcription factors). In this communication, we review the role of OSRts, notably NRF2 and p53 as well as other transcription factors that modulate the response. We discuss how hierarchal the oxidative stress response is and controls ‘live or die’ signals. This is followed by a discussion on how plant-derived molecules, including polyphenols, which are described both as prooxidants and antioxidants within the cancer cells, have been reported to affect the activities of OSRts. Deriving an example from preliminary data from our group, we discuss how plant-derived molecules might modulate the oxidative stress response by causing structural perturbations in the proteinaceous transcription factors, notably Nrf2 and p53. We look at this information in the light of understanding how plant derived molecules may be used as lead compounds to develop modulators of the oxidative stress response.
- Open Access
- 24 September 2021
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 17 (4) , 87-89
Obstructive Coronary Atherosclerosis in a Patient with a Calcium Score of Zero
Museum images feature novel multimodality imaging that illuminates the important role of imaging in the diagnosis and management of on unusual cases and conditions. Image files should be accompanied by a contextual description of approximately 100 to 300 words. Videos are welcome, and abstracts are unnecessary. To submit museum images to be considered for peer review, please visit journal.houstonmethodist.org .
- 24 September 2021
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 17 (4) , 87-89
Open AccessObstructive Coronary Atherosclerosis in a Patient with a Calcium Score of Zero
Museum images feature novel multimodality imaging that illuminates the important role of imaging in the diagnosis and management of on unusual cases and conditions. Image files should be accompanied by a contextual description of approximately 100 to 300 words. Videos are welcome, and abstracts are unnecessary. To submit museum images to be considered for peer review, please visit journal.houstonmethodist.org .